Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05964829 · ClinicalTrials.gov registry record · NA
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
A NA study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), sponsored by Cionic.
- Recruiting
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT05964829: Recruiting NA study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), sponsored by Cionic.
NCT05964829 is a NA study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting) that is actively recruiting participants, run by Cionic. The registered enrollment target is 14 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05964829, a NA study of Multiple Sclerosis and Multiple Sclerosis (Relapsing Remitting), is actively recruiting participants, sponsored by Cionic.
- RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).
Primary Outcome
The Timed 25-Foot Walk Test (T25FWT) to record duration of time to walk a distance of 25 feet, measured in seconds. The score is the average of two successive trials.
Conditions Studied
Interventions
- DEVICE Cionic Neural Sleeve NS-100
- BEHAVIORAL Walking Program
Study Locations (1)
Ohio
- Cleveland State University - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2023-09-04 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05964829 shows while recruiting
NCT05964829 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Cionic Neural Sleeve NS-100 is the first listed.
NCT05964829 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05964829 about?
NCT05964829 is a clinical study titled "Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis". The purpose of this research is to support the clinical value of the Cionic Neural Sleeve for individuals diagnosed with multiple sclerosis (MS).
What is the current status of trial NCT05964829?
This trial is currently recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2023-09-04. Estimated completion is 2026-07.
What conditions does trial NCT05964829 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Multiple Sclerosis (Relapsing Remitting), Multiple Sclerosis, Chronic Progressive.
What interventions are being tested in trial NCT05964829?
The interventions under investigation include: Cionic Neural Sleeve NS-100 (DEVICE), Walking Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05964829?
This trial is sponsored by Cionic, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05964829 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05964829's enrollment target sits among peer trials
14 291st of 315 higher than 23 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy